Technical Analysis for PALI - Palisade Bio, Inc.

Grade Last Price % Change Price Change
F 2.77 1.84% 0.05
PALI closed up 1.84 percent on Friday, November 1, 2024, on 1.36 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 7
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 1.84%
Hammer Candlestick Bullish 1.84%
Lizard Bullish Bullish Day Trade Setup 1.84%
Gilligan's Island Buy Setup Bullish Swing Setup 1.84%
Volume Surge Other 1.84%

   Recent Intraday Alerts

Alert Time
Gap Down Closed about 24 hours ago
Reversed from Down about 24 hours ago
Gilligan's Island Bullish Entry about 24 hours ago
Lizard Bullish Entry about 24 hours ago
Hammer Candlestick Entry about 24 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Palisade Bio, Inc. Description

Palisade Bio is a late-stage biopharma company advancing therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. Positive data from Phase 2 trials of LB1148 demonstrated safety and tolerability as well as a statistically significant improvement in return to bowel function and decrease in length of stay in ICU and hospital compared to placebo. Palisade Bio believes that its investigational therapies have the potential to address the myriad health conditions and complications associated with chronic disruption of the gastrointestinal epithelial barrier.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Surgery Abdominal Pain Gastrointestinal Tract Digestive System

Is PALI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.35
52 Week Low 2.18
Average Volume 83,921
200-Day Moving Average 5.01
50-Day Moving Average 3.53
20-Day Moving Average 3.45
10-Day Moving Average 3.38
Average True Range 0.33
RSI (14) 32.89
ADX 22.36
+DI 15.53
-DI 34.58
Chandelier Exit (Long, 3 ATRs) 3.34
Chandelier Exit (Short, 3 ATRs) 3.16
Upper Bollinger Bands 4.05
Lower Bollinger Band 2.84
Percent B (%b) -0.06
BandWidth 34.97
MACD Line -0.15
MACD Signal Line -0.05
MACD Histogram -0.0937
Fundamentals Value
Market Cap 33.6 Million
Num Shares 12.1 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 8.66
Price-to-Sales 21.88
Price-to-Book 0.39
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.16
Resistance 3 (R3) 3.14 2.98 3.10
Resistance 2 (R2) 2.98 2.88 3.00 3.07
Resistance 1 (R1) 2.88 2.82 2.93 2.90 3.05
Pivot Point 2.72 2.72 2.75 2.74 2.72
Support 1 (S1) 2.62 2.62 2.67 2.64 2.49
Support 2 (S2) 2.46 2.56 2.48 2.47
Support 3 (S3) 2.36 2.46 2.45
Support 4 (S4) 2.38